NMG
ADMA icon

New Millennium Group’s ADMA Biologics ADMA Stock Holding History

New Millennium Group’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$328 Sell
18
-620
-97% -$10.4K ﹤0.01% 361
2025
Q3 		$9.35K Sell
638
-2,927
-82% -$50.2K ﹤0.01% 224
2025
Q2 		$64.9K Buy
3,565
+1,998
+128% +$40.7K 0.04% 85
2025
Q1 		$31.1K Sell
1,567
-212,742
-99% -$3.68M 0.02% 121
2024
Q4 		$3.68M Buy
214,309
+7,246
+3% +$136K 2.15% 14
2024
Q3 		$4.14M Buy
+207,063
New +$3.22M 2.67% 12

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

New Millennium Group's ADMA Position: Q4 2025 in Review

New Millennium Group reduced its ADMA Biologics (ADMA) stake by 97% in Q4 2025, selling an estimated $10.4K and leaving 18 shares worth $328. The position accounts for ﹤0.01% of the portfolio, ranked #361.

New Millennium Group first reported a position in ADMA in Q3 2024 and has held it in 6 quarters since. The position peaked at $4.14M in Q3 2024. 356 funds tracked by Wall St. Rank hold ADMA as of Q4 2025.

  • New Millennium Group held 18 shares of ADMA Biologics worth $328 as of Q4 2025.
  • New Millennium Group sold 620 ADMA Biologics shares in Q4 2025, an estimated $10.4K.
  • ADMA Biologics made up ﹤0.01% of New Millennium Group's portfolio in Q4 2025, its #361 holding.
  • New Millennium Group first reported a position in ADMA Biologics in Q3 2024 and has held it in 6 quarters since.
  • New Millennium Group's ADMA Biologics position peaked at $4.14M in Q3 2024.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q4 2025.

Based on New Millennium Group's 13F filing for Q4 2025, filed 6 Feb 2026.